Stage IIIC Esophageal Cancer AJCC v7 Recruiting Phase 1 / 2 Trials for Ramucirumab (DB05578)

IndicationStatusPhase
DBCOND0088905 (Stage IIIC Esophageal Cancer AJCC v7)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03008278Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by SurgeryTreatment